Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 216001
Company: SINOTHERAPEUTICS INC
Company: SINOTHERAPEUTICS INC
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
TOFACITINIB | TOFACITINIB | 11MG | TABLET, EXTENDED RELEASE;ORAL | None (Tentative Approval) | None | No | No |
TOFACITINIB | TOFACITINIB | 22MG | TABLET, EXTENDED RELEASE;ORAL | None (Tentative Approval) | None | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
08/08/2023 | ORIG-1 | Tentative Approval | STANDARD |
Label is not available on this site. |